Our results provided potential mechanistic insight into the role of periostin in the pathophysiology of DCM, and suggested that GA served as a promising compound for therapeutic interventions against DCM by targeting periostin. The gene discussed is POSTN; the disease is familial dilated cardiomyopathy.